Two Classes of DNA Gyrase Inhibitors Elicit Distinct Evolutionary Trajectories Toward Resistance in Gram-Negative Pathogens

Semen A. Leyn(Agilent Technologies (United States)), Andrei L. Osterman(Sanford Burnham Prebys Medical Discovery Institute)
bioRxiv (Cold Spring Harbor Laboratory)
June 27, 2023
Cited by 3


Related Papers